Introducing the
Tentarix platform

Our Science Begins Where
Traditional Biologics Fall Short

VH-Select™

Building Stable, Fully Human Scaffolds

Our proprietary VH-Select™ technology encompasses all 47 functional human VH genes, engineered for exceptional thermal stability and developability, laying the foundation for safer, more effective biologics.

FunctionSeq™

Screening for Optimal Conditional Activity

FunctionSeq™ is our mammalian display and flow cytometry-based screening platform that enables high-throughput discovery of Tentacles™ with precise conditionality and optimized function.

Tentacles™

Targeting the Right Cells at the Right Time

Tentacles™ are multifunctional, conditionally active molecules designed to selectively engage specific cell types, enabling powerful therapeutic effects while avoiding systemic toxicity.

Unique in the Industry: Stabilized Human VHs

Overcoming historical challenges with single-domain binders that limit other platforms

Industry standard: Camelid VHH (Nanobody)
Camelid VHH binders are a common industry scaffold

Challenges:

  • Lengthy immunizations

  • Limited repertoires

  • Humanization required

  • Immunogenicity

Emerging scaffold: Fully Human VH
Human VH rodents have been developed as an emerging scaffold

Challenges:

  • Low VH stability requires engineering

  • Limited VH diversity

  • VH binding to antibody light chains

  • VH homodimerization

VH-Select™

Differentiated and Stabilized Fully Human VH Binders

  • Little to no engineering of binders required: improves probability of success and shortens R&D timelines

  • Patent application filed that covers stabilization of all 47 functional VH domains in the human genome (encompassing all germline VH families, VH1–VH7)

FunctionSeq™

Discovering Tentacles with optimal activity and cell specificity requires building and screening large Tentacle libraries (>10⁵) inaccessible to most screening platforms

Tentarix leverages mammalian display to functionally evaluate large Tentacle libraries with the capacity to investigate:

  • Varied binder epitope and affinities

  • Varied Tentacle geometries

  • Varied linker lengths

Mammalian Display Reporter System for Identifying
Conditional Agonists (Tentacles™)

Proof-of-Concept Agonist with >1,000x Conditionality